The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
STRIvE-02 Arm C: Phase 1 study of concurrent PD-1 inhibition with B7-H3 CAR T cell immunotherapy for recurrent/refractory pediatric solid tumors.
 
Michelle Choe
No Relationships to Disclose
 
Mallory Taylor
No Relationships to Disclose
 
Jason Wendler
No Relationships to Disclose
 
Prabha Narayanaswamy
No Relationships to Disclose
 
Stephanie Rawlings-Rhea
No Relationships to Disclose
 
Kristy Seidel
Employment - Seattle Children's Hospital
Stock and Other Ownership Interests - Abbvie
 
Wenjun Huang
No Relationships to Disclose
 
Sowmya Pattabhi
No Relationships to Disclose
 
Danielle Gamble
Employment - Seattle Children's Hospital
 
On Ho
No Relationships to Disclose
 
Ashley Wilson
No Relationships to Disclose
 
Stephanie Mgebroff
No Relationships to Disclose
 
Christopher Brown
No Relationships to Disclose
 
Catherine Lindgren
No Relationships to Disclose
 
Colleen Annesley
No Relationships to Disclose
 
Rebecca Alice Gardner
Honoraria - crispr therapeutics; Novartis; SOBI; SOBI
Research Funding - 2seventy bio
Patents, Royalties, Other Intellectual Property - IP and royalties are received from BMS related to CAR technology patents
Travel, Accommodations, Expenses - Novartis
 
Michael Jensen
No Relationships to Disclose
 
Julie R. Park
Patents, Royalties, Other Intellectual Property - Patent licensed to Umoja Pharmaceuticals, no monetary value to date
 
Catherine Michelle Albert
No Relationships to Disclose
 
Navin Pinto
Consulting or Advisory Role - Eureka Therapeutics; Novartis
Patents, Royalties, Other Intellectual Property - I hold a patent 20210346431 that has been licensed to Umoja Biotherapeutics and may result in royalty payments. No payments have been received to date.
(OPTIONAL) Uncompensated Relationships - US WorldMeds; Y-mAbs Therapeutics